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Abstract
Background: Influenza immunisation for healthcare workers is encouraged to protect their often vulnerable
patients but also due to a perceived higher risk for influenza. We aimed to compare the risk of influenza infection
in healthcare workers in acute hospital care with that in non-healthcare workers over the same season.
Methods: We conducted a prospective, multicentre cohort study during the 2006/07 influenza season in Berlin,
Germany. Recruited participants gave serum samples before and after the season, and completed questionnaires to
determine their relevant exposures and possible confounding factors. The main outcome measure was serologically
confirmed influenza infection (SCII), defined as a fourfold or greater rise in haemagglutination inhibition antibody
titres to a circulating strain of influenza (with post-season titre at least 1:40).
Weekly mobile phone text messages were used to prompt participants to report respiratory illnesses during the
influenza season. A logistic regression model was used to assess the influence of potential risk factors.
Results: We recruited 250 hospital healthcare workers (mean age 35.7 years) and 486 non-healthcare workers
(mean age 39.2 years) from administrative centres, blood donors and colleges.
Overall SCII attack rate was 10.6%. Being a healthcare worker was not a risk factor for SCII (relative risk 1.1, p =
0.70). The final multivariate model had three significant factors: living with children (odds ratio [OR] 3.7, p = 0.005),
immunization (OR 0.50, p = 0.02), and - among persons living in households without children - ownership of a car
(OR 3.0, p = 0.02). Living with three or more children (OR 13.8, p < 0.01) was a greater risk than living with one or
two children (OR 5.3, p = 0.02). 30% of participants with SCII reported no respiratory illness. Healthcare workers
were at slightly higher risk of reporting any respiratory infection than controls (adjusted OR 1.3, p = 0.04, n = 850).
Conclusions: Our results suggest that healthcare workers in hospitals do not have a higher risk of influenza than
non-healthcare workers, although their risk of any respiratory infection is slightly raised. Household contacts seem
to be more important than exposure to patients. Car ownership is a surprise finding which needs further
exploration. Asymptomatic infections are common, accounting for around a third of serologically confirmed
infections.
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The German standing commission for immunisation,
along with other authorities [1-3] currently recommends
that healthcare workers (HCWs) be vaccinated against
seasonal influenza. Two reasons are cited: firstly that
HCWs can be a source of infection for vulnerable peo-
ple under their care [1-3], and secondly that HCWs are
at increased risk for contracting influenza [1]. Vaccina-
tion of HCWs should theoretically reduce the risk of
influenza infection both in themselves and their patients.
There is evidence to support the first reason for vacci-
nation, the protection of patients. HCWs can transmit
influenza to those under their care during both out-
breaks and non-outbreak situations [4-7]. Low vaccina-
tion rates in HCWs have been associated with
nosocomial outbreaks [4,8], and higher vaccination rates
with reduced nosocomial influenza incidences [7].
HCWs may transmit influenza to those under their
care, but is there evidence that their occupational expo-
sures (to patients, relatives, colleagues and the hospital
environment) confer an increased risk of influenza com-
pared to the general population? Influenza serological
attack rates in HCWs of 23% (single season, [9]) and
14% (an average of two seasons, [10]) have been docu-
mented. However, as serological attack rates of influenza
may vary considerably from season to season as well as
from location to location, without the inclusion of a
comparison group of non-HCWs neither study could
demonstrate an increased risk.
Another aspect of influenza in HCWs is that many
HCWs argue that they withdraw from work when they
become ill with influenza-like illness to reduce their risk
of transmitting influenza to their patients. However, not
all serologically diagnosed influenza infections experi-
ence an influenza-like illness, and a proportion will be
asymptomatic. The frequency of asymptomatic influenza
infection in HCWs has been assessed in volunteer stu-
dies (33%, [11]), a cohort study (28%, [9]) and one ran-
domised controlled study (42%, [10]).
The objective of this study was to address the ques-
tion of whether HCWs in the acute care hospital setting
have a higher risk of serologically confirmed influenza
infections (SCII) than non-HCWs, and to assess the
proportion of individuals with SCII who experience
either any respiratory symptoms or an influenza-like
illness.
Methods
We conducted our study in people living or working in
Berlin during the influenza season of 2006/07, using a
multicentre, prospective cohort design.
There were 11 study sites: three hospitals, two admin-
istrative centres (the Robert Koch Institute and Vivantes
Healthcare administrative centre), four blood-donation
centres and two colleges. HCWs and some non-HCWs
were sought from the hospitals, but only non-HCWs
were sought from all other sites.
We recruited participants through occupational health
services in the hospitals and one administrative centre;
through direct recruitment at blood donation centres;
and through active recruitment during site visits at the
other study sites (non-healthcare workers from one
administrative centre and two colleges).
On recruitment before the influenza season, consent-
ing participants gave a single serum sample and com-
pleted an exposure questionnaire. Details recorded
included age, sex, type of employment, risk factors for
influenza, smoking status, and vaccination status. Where
participants had been vaccinated fewer than 14 days
before the sample was taken, or were found to have
been vaccinated shortly after the initial sample was
taken, a second sample, taken at least 14 days after vac-
cination, was sought through direct recall or through
occupational health.
Blood samples were refrigerated, then transported
within three days to the national reference laboratory
for influenza at the Robert Koch Institute in Berlin,
where they were centrifuged and frozen.
Inclusion and exclusion criteria
HCW in our context were defined as people working on
a daily basis with unwell patients in an acute hospital
setting, including nurses (trainee and qualified) and doc-
tors. Non-HCW were those working or studying at the
study sites, or attending the blood donation centres,
who did not fit the definition of HCW.
Exclusions (applied to both HCWs and non-HCWs)
were: people with patient contact in the community
(such as community doctors and nurses, dentists, and
pharmacists); people working in care homes; laboratory
workers who had contact with respiratory samples or
w i t hi n f l u e n z av i r u s ;p e o p l ew h op l a n n e dt ob ea w a y
from Berlin for more than two weeks during the pro-
jected season (January to April); and people who did not
wish to be contacted weekly by mobile phone Short
Message System (SMS) or email.
For the analysis of serologically-confirmed infections,
we excluded vaccinated individuals where the baseline
serum sample was taken fewer than 14 days after vacci-
nation, or where a later second sample was not obtain-
able (see recruitment above). These participants were
excluded from the serological analyses as any titre rise
could have been caused by vaccination and not infection.
Because pigs can carry influenza viruses, and partici-
pants with pig contact were associated with SCII, parti-
cipants reporting contact with pigs were excluded.
Williams et al. BMC Infectious Diseases 2010, 10:8
http://www.biomedcentral.com/1471-2334/10/8
Page 2 of 11Active surveillance for respiratory infections during
influenza season
In order to document weekly occurrences of respiratory
infections during the influenza season, we contacted all
participants weekly through SMS or through email, ask-
ing them if they had experienced a “new” respiratory
infection during the previous 7 days. Where participants
answered “yes”, they were contacted by telephone and
details of their infection were obtained using an illness
questionnaire.
Weekly surveillance for respiratory infections covered
the period from January 13, 2007 to March 30, 2007, a
period chosen to coincide with the influenza season.
This strategy was employed in order to maximise the
predictive value of a positive answer.
Postseason follow-up
After the influenza season, participants were recalled by
SMS or email. They gave a second serum sample and
completed a further questionnaire, including repeat
questions on vaccination status and employment type;
number of patient contacts on a typical day between
January 13 and April 6, 2007; broad age classification of
patient contacts (adults (>17 years) and children (<18
years); clinical specialty and usage of facemasks (for
HCWs); daily professional and household contacts; use
of public transport and car ownership; contact with pigs
(for veterinary students); and vaccination in previous
years. Participants were asked again if they had had
respiratory infections over the period January 13, 2007
to 6
th April 2007, extending the period of surveillance to
one week after the last weekly SMS was sent.
Contact was defined as either touching or having a two
way conversation with someone close by, or (for patient
contact only) examining or giving care to a patient. Partici-
pants were asked to estimate the number of contacts made
during a typical day in household and work settings.
Laboratory investigations
The paired blood samples were defrosted and antibody
titres were determined on the same day using the hae-
magglutination inhibition test to determine infection in
any of the two A subtypes or the two B lineages. We
tested for antibody to the following strains:
A/H1: A/New Caledonia/20/1999 (H1N1)
A/H3: A/Wisconsin/67/2005 (H3N2), and A/Califor-
nia/07/2004 (H3N2)
B, Victoria lineage: B/Malaysia/2506/2004
B, Yamagata lineage: B/Jiangsu/10/2003.
Titres of below 10 were assigned the value of 5 in
order to allow calculation of the titre rise. SCII was
defined as a fourfold or greater titre rise between pre-
and post-season samples, with a postseason titre of at
least 40. As A/Wisconsin/67/2005 (H3N2) and A/
California/07/2004 (H3N2) were closely related a titre
rise to either of these strains was considered as a single
SCII due to A/H3N2.
Outcomes
The primary outcome was evidence of SCII by any of
the above strains.
The clinical outcomes were influenza-like-illness (ILI),
defined as an illness with an acute onset, self-reported
fever, cough, and head or body pains; and acute respira-
tory infection (ARI), defined as any reported infection
with coryza (nasal discharge) or cough. Clinical out-
comes were based only on completed illness question-
naires or postseason illness reports, not on SMS or
email replies, the latter being used only as the prompt
for collection of illness data.
Where illness was reported over more than one week,
symptoms for each week were combined to produce a
single illness episode. To produce an epidemic curve of
SCII with any ILI, or in its absence, another ARI, the
respective dates of illness onset were plotted. Where
more than one illness episode was reported, we used the
onset date of the episode closest to the peak, on the
assumption that this episode was the most likely to be
due to influenza virus.
Statistical analysis
We undertook bivariate analyses for all binary exposure
variables and calculated risk ratios (RR), their 95% confi-
dence interval and p-values. For the comparison of the
exposure groups (HCW vs. non-HCW) continuous vari-
ables were analysed using the Kruskal-Wallis test. For
the analysis of the association with SCII continuous
variables were explored by grouping them in categories.
We regarded a p-value of less than 0.05 as statistically
significant. We then constructed a multivariate logistic
regression model (logistic command, STATA [StataCorp.
2007. Stata statistical software: Release 10. College Sta-
tion, TX: Statacorp LP]) using variables which were
associated with the outcome with a p-value of less than
0.1 in the bivariate analysis. Variables with p values
between 0.1 and 0.2, along with healthcare worker sta-
tus, were also tested in the final model.
In order to determine whether the site of recruitment
had any group-level effects on the model, we con-
structed a random-effects logistic regression model with
the same variables as the standard model plus study site
as the grouping variable, and a likelihood ratio test for
the proportion of variance attributable to the group
level (rho) was performed (xtlogit, STATA).
Data protection and ethical approval
The data protection protocol was approved by both
state and national data protection offices in Berlin, and
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study was obtained from the University of Berlin, faculty
of medicine (Charité) ethics committee.
Results
Recruitment and follow-up
We recruited 1044 participants, of which 736 (71%)
were included in the analysis with SCII as outcome, and
866 (93%) for the clinical outcome analysis (Figure 1).
Those not included in the study were of younger age
(38 vs 34, p < 0.01 Kruskall-Wallis) and were more
likely to be HCW at recruitment (42% vs 34%, p < 0.01),
but there were no significant differences in sex, current
immunisation, smoking status, car ownership or use of
public transport in excluded versus non-excluded
participants.
Comparison of study participants by healthcare worker
status
Of the 736 participants included in the analysis with the
outcome SCII 250 (34%) were HCWs and 486 (66%)
were non-HCWs. Most participants (71%) were female.
The age distribution was bimodal, with peaks in the age
groups 20-29 years and 40-49 years both in HCWs and
non-HCWs.
Of the 250 healthcare workers, 41 (16%) were doctors,
97 (39%) were trainee nurses and 112 (45%) were quali-
fied nurses. Of the 486 non-healthcare workers, 178
(36%) were administrative or information technology
staff, 107 (22%) scientific staff, 45 (9%) students, 6 (1%)
teaching or lecturing staff, 25 (5%) in manual or techni-
cal roles, 21 (4%) in retail or service, 9 (2%) veterinary
staff, and 7 (1%) in other occupations. In 88/486 (18%)
the occupation was not stated or unclear.
Table 1 compares study characteristics in the exposure
group (HCW) and control group (non-HCW). HCWs
were significantly younger than controls (35.7 versus
39.2, Kruskal-Wallis test, p < 0.01). They were also sig-
nificantly more likely to be current smokers, female,
vaccinated in the current season, and to own a car.
Healthcare workers had significantly more non-patient
contacts at work (mean 14.3 versus 13.8, p = 0.021) but
fewer contacts at home (mean 2.7 versus 3.5, P < 0.01)
There were no significant differences in immunisation
in the previous three seasons, or in household exposure
to children. HCWs were significantly less likely to have
a titer of <40 against A/California/07/2004, the A/
H3N2-strain of the previous season.
Serologically confirmed influenza infection and ILI/ARI
In total there were 82 titer rises among 78 participants.
Of these, 13 (16%) were due to A/New Caledonia/20/
1999 (H1N1), 64 (78%) due to either of the two A/
H3N2-strains tested, two (2%) due to B/Malaysia/2506/
2004 and three (4%) due to B/Jiangsu/10/2003. There
were four double-infections, three with H3N2/H1N1 co-
infections and one with titre rises to both B strains.
Table 2 shows SCII and reported infections by health-
care worker status. The overall attack rate for SCII was
10.6% (78/736). Of the 78 people with evidence of SCII,
23 (30%) reported neither ARI nor ILI, 33 (42%)
reported at least one ARI but no ILI, and 22 (28%)
reported at least one ILI.
Bivariate analysis: risk factors for SCII
HCWs did not have a significantly higher risk of SCII
than non-HCWs (RR 1.09, p = 0.70). In addition, neither
working as a nurse (RR = 0.94, p = 0.82) nor as a doctor
was significant (RR = 1.76, p = 0.13). There was also no
significant difference in the risk of SCII between HCWs
and controls after stratification by vaccination status, car
ownership, having children, or regular use of public
transport.
There were three exposures with p-values below 0.1:
vaccination, having a car in the household and having
three or more children at home (Table 3). Household
contacts increased the unadjusted risk of SCII (Figure
2). Attack rates were lowest in those living alone (4%),
intermediate in those living with adults but no children
(10%) or one or two children( 1 2 % ) ,a n dh i g h e s ti n
those with three or more children in the household
(24%). In a stratified analysis, the effect of car owner-
ship was significant when participants did not live with
children (RR = 2.77, p = 0.01), but not for participants
who lived in a household with children (RR = 0.98,
p = 1.00).
Multivariate model
Variables significantly associated with SCII were the
type of household contact environment, car ownership,
and vaccination status (Table 4). Living with children
was associated with an increased risk of SCII, with an
overall odds ratio of 3.7 (p < 0.01, separate model
without stratification of household contacts). Three or
more children in the household (OR13.8, p < 0.01)
were a greater risk than one or two children (OR 5.3,
p = 0.02).
Household car ownership was a significant risk factor
only among persons living in households without chil-
dren and had an odds ratio for SCII of 3.0 (p = 0.02),
while owning a car in households with children was not
statistically significant (OR = 0.95; p = 0.94) and so was
not included in the final model.
Immunisation against influenza was associated with an
OR of 0.50 (p = 0.02). Vaccine effectiveness against SCII
was therefore 50% (95%CI 12-71%). Effectiveness against
SCII with a reported ILI was higher at 73% (95%CI 6-
92%; p = 0.04).
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but were found not to be significant at the p < 0.2 level.
T h e s ew e r eb e i n gad o c t o r ;h a v i n g7o rm o r ec h i l d
patient contacts; and being a healthcare worker. Addi-
tion of a group-level variance term for recruitment site
to the random-effects model was not statistically signifi-
cant (p(rho = 0) > = 0.498).
Risk factors for any ARI
The four variables with a p-value < 0.2 in the bivariate
analysis were age below 51 (p = 0.02), female sex (p =
0.03), HCW (p = 0.03) and smoking (p = 0.12). In the
multivariate model (n = 850) all except female sex (p =
0.054) were significant, and the effect of smoking
became statistically significant. Age below 51 (OR 1.44,
p = 0.04), female sex (OR 1.36, p = 0.05) and HCW sta-
tus (OR 1.34, p = 0.04) had an OR above 1, and smok-
ing had an OR below 1 (OR 0.72, p = 0.04).
Temporal progression of influenza cases
Figure 3 shows the distribution of dates of onset for
all SCII where an episode of ARI or ILI was reported.
The peak seen in week 9 corresponded with the peak
number of positive influenza tests from Berlin
patients performed at the national reference labora-
tory for influenza, from patient samples collected
through the German influenza sentinel surveillance
system [12].
Discussion
We found no significant association between being a
healthcare worker in acute hospital care and serogically
confirmed influenza infection. Instead we identified
household contacts, in particular children, and car own-
ership, as important risk factors for SCII. 30% of partici-
pants with SCII reported no symptoms, and only
around one-quarter of those reporting influenza-like ill-
ness also had SCII.
We did not demonstrate a strongly increased risk of
influenza infection in HCWs in acute hospital care. As
HCWs do appear to have an increased risk for ARI (OR
= 1.3) it would be plausible to expect an effect of similar
order for influenza infections. Although study limita-
tions might have led to a failure to detect a true
Table 1 Characteristics of study participants, by healthcare worker status
Exposure (n = 736 unless otherwise specified) Healthcare workers
(N = 250)
Non-Healthcare workers
(N = 486)
P (chi-squared, unless
otherwise specified)
Age, mean (years) 35.7 39.2 P < 0.001
(Kruskal-Wallis)
Male sex (%) 57 (22.8%) 160 (32.9%) P < 0.001
Immunisation in current season (2006/07) (n = 736) 104 (41.6%) 153 (31.5%) 0.006
Immunised 2005/6 (n = 728) 103 (41.7%) 184 (38.3%) 0.37
Immunised 2004/5 (n = 712) 77 (32.1%) 162 (34.3%) 0.55
Immunised 2003/4 (n = 696) 53 (22.7%) 132 (28.6%) 0.10
Current smoker at recruitment (n = 726) 99 (40.6%) 125 (25.9%) P < 0.01
Children at home 87 (34.8%) 144 (29.6%) 0.15
Patient contacts (per typical day) 30.8 Not applicable
Contacts at work (per typical day, excluding patients), mean
(n = 730)
14.3 13.8 0.021
(Kruskal-Wallis)
Contacts at home (per typical day), mean 2.7 3.5 P < 0.001
(Kruskal-Wallis)
Car owner (n = 727) 199 (80.6%) 352 (73.3%) 0.03
Regular use of public transport (n = 733) 128 (51.6%) 303 (62.5%) 0.005
Preseasonal titer of <40 against A/California/07/2004 (H3N2)
among non-vaccinated
97 (69.7%) 269 (79.1%) 0.03
Table 2 Serologically confirmed influenza infections (SCII) by healthcare worker status and reported respiratory illness
(n = 736)
Number with SCII (% in illness group)
Reported illness N Healthcare workers Non-healthcare workers All
No reported illness 421 8 (5.9) 15 (5.3) 23 (5.5)
Acute respiratory infection (excluding ILI) 231 11 (13.9) 22 (14.5) 33 (14.3)
Influenza-like illness (ILI) 84 9 (25.7) 13 (26.5) 22 (26.2)
Total 736 28 (11.2) 50 (10.3) 78 (10.6)
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Page 6 of 11Figure 2 Unadjusted attack rates for serological influenza infection by category of household contacts (n = 736).
Table 3 Attack rates (AR) and relative risks for persons with serologically confirmed influenza infection (SCII) as
outcome, by exposure (n = 736), sorted by p-value
Exposed Unexposed
Exposure SCII Total AR% SCII Total AR% Relative risk 95% confidence interval P-value
Household car ownership 66 551 12.0 10 176 6 2.11 1.11-4.01 0.02
Immunisation in current season 18 257 7.0 60 479 13 0.56 0.34-0.93 0.02
Household contacts
Lives alone 3 75 4.0 - - - Ref --
Lives with adults 43 430 10.0 - - - 2.50 0.80-7.85 0.13
1 or 2 children 24 198 12.1 - - - 3.03 0.94-9.77 0.07
3 or more children 8 33 24.2 - - - 6.06 1.72-21.41 <0.01
7 or more daily child patient contacts 8 45 17.8 70 691 10.13 1.75 0.90-3.42 0.11
Doctor 7 39 18.0 71 697 10.19 1.76 0.87-3.57 0.13
Being employed 70 685 10.2 8 51 15.69 0.65 0.33-1.28 0.22
Current smoker (at recruitment) 28 224 12.5 50 502 9.96 1.25 0.81-1.94 0.31
Male sex 25 217 11.5 53 519 10.21 1.13 0.72-1.77 0.60
Working 30+ hours per week 60 581 10.3 18 155 11.61 0.89 0.54-1.46 0.64
Healthcare worker 28 250 11.2 50 486 10.29 1.09 0.70-1.68 0.70
Regular public transport use 47 431 10.9 31 302 10.26 1.06 0.69-1.63 0.78
Nurse (qualified or trainee) 20 206 9.7 50 486 10.29 0.94 0.58-1.54 0.82
Age 16-24 years 18 177 10.2 60 559 10.7 0.95 0.57-1.56 0.83
Age 25-49 years 44 392 11.2 34 344 9.9 1.14 0.74-1.73 0.56
Age 50+ years 16 167 9.6 62 569 10.9 0.88 0.52-1.48 0.78
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ence in the risk of influenza.
Why might HCWs in hospital not have a higher risk
of influenza? The prevalence of infectious influenza in
patients may have been low, either due to the absence
of influenza patients or because patients admitted later
in the course of illness might have been less infectious.
Also, infection control measures such as use of personal
protective equipment and individual or cohort isolation
might have reduced the risks of infection in HCWs.
Lastly, prior immunity may have played a role. HCWs
were less likely than non-HCWs to be susceptible (pre-
season titer of less than 40) to A/California/07/2004
(H3N2), which was the A/H3N2 strain of the previous
season and related to A/Wisconsin/67/2005 (H3N2), the
dominant strain in the 2006/07 season.
As most influenza patients admitted to hospitals are
children or older people, one might expect to find an
increased risk for SCII in HCWs who work with these
patient groups. Our finding of an elevated odds ratio for
HCWs with more frequent contact with child patients,
albeit not significant in this setting, would be consistent
with this supposition. Another study focusing on this
hypothesis is needed to investigate it further.
Household contacts, and in particular children in the
home, were the main significant risk factors identified in
Table 4 Logistic regression model for persons with serologically confirmed influenza infection as outcome (n = 727)
Exposure Number exposed Odds Ratio
1 P-value 95% confidence interval
Immunisation 257 0.50 0.02 0.29-0.88
Household contacts
Lives alone 75 ref - -
Lives with adults 430 2.0 0.28 0.58-6.70
1 or 2 children 198 5.3 0.02 1.33-21.12
3 or more children 33 13.8 0.001 2.97-64.27
Lives without children and has a car 352 3.0 0.02 1.21-7.25
1 - adjusted for all other variables in model
Figure 3 Cases of serologically confirmed influenza infection reporting acute respiratory illness (ARI; blue) and influenza-like illness
(ILI; red), by date of onset of reported illness (n = 53). Green line (on secondary y-axis): smoothed line of influenza cases in Berlin identified
at the national reference laboratory for influenza from samples collected within the German sentinel surveillance system [12].
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plet-transmitted infection, meningitis, where household
contacts constitute by far the most important risk group
[13]. We found a strong dose-response relationship for
child household contacts. The role of children as the
main sources of influenza transmission has been sug-
gested in several studies [14-17]. Adult household con-
t a c t sm a yp l a yar o l ea n a l o g o u s ,b u tp o s s i b l yl e s s
marked, to that of children.
Whilst public transport usage was not associated with
SCII, car ownership was a significant risk factor, albeit
only in households without children. This was unex-
pected, as car ownership was only included as a coun-
terpart question to public transport usage. For this
reason, further details on passengers, frequency or dura-
tion of car use were not obtained in the study.
Possession of a car has not previously been recog-
nised as a risk factor for influenza acquisition. How-
ever, sharing a car does involve prolonged close
contact in an enclosed space and has been linked to
transmission of one airborne pathogen [18]. In one
observational study on risk factors for SARS in China
“using a taxi more than once a week” was identified as
independent risk factor for SARS infection with an
increased odds ratio close to significance (p = 0.07).
Furthermore, this variable was kept in the multivariate
model while “riding a bus” and “taking the subway”
(who were significant in bivariate analysis) were not
[19]. Ownership of a car may also be a marker for hav-
ing a greater number of social contacts, perhaps
including children. Car users are also exposed to air
pollution from other vehicles, and this may predispose
users to respiratory infections. Despite the unexpected
nature of this finding, it is possible that car usage is
indeed a risk factor and should be explored through
further studies.
We did not find an increased risk of influenza in the
58% of participants who were regular users of public
transport. Public transport usage has been cited as a
possible risk factor for influenza infection, particularly
in the context of pandemic planning [20]. In a recent
international survey of precautionary behaviour for pan-
demic influenza, 75% of respondents said that they
would avoid public transport [21]. Both rail and air tra-
vel have been associated with respiratory infection trans-
mission [22,23]. Whilst it is possible to contract
influenza on public transport, our results suggest that,
at least in Berlin, using public transport does not
increase a person’s risk of influenza. In Berlin, crowding
on public transport is infrequent and not extreme, so
this result may not be generalisable to cities with differ-
ent conditions.
Vaccine uptake was relatively high both in HCWs
(42%) and non-HCWs (32%). Reasons for this high
HCW uptake include the participation of a hospital
from former East Germany where vaccination uptake
in hospitals is still found to be higher than in West
German hospitals. In non-HCWs, the participation of
a federal public health institute where influenza vacci-
nation is freely offered to employees may account for
the high vaccination rate. High vaccination uptake lim-
ited the number of SCII and reduced the study power.
Vaccination effectiveness was 50% against SCII and
reached 73% for a more severe outcome, SCII with
reported ILI.
Only 28% of participants with SCII reported an ILI,
the majority reporting no symptoms or more minor
respiratory illness. The proportion of asymptomatic
infections (30% or more) was substantial and similar to
that reported by Elder (28%,[9] and consistent with an
estimated proportion of 33% obtained from pooled chal-
lenge studies [10]. In addition, only 26% of persons with
an ILI had evidence of an influenza infection. Thus, the
ILI-syndrome was a poor marker for influenza infec-
tions. Unvaccinated HCWs who intend to withdraw
from work when they become ill with influenza-typical
symptoms may overlook many (symptomatic or asymp-
tomatic) influenza infections, putting patients at unne-
cessary risk.
The association of HCW status and ARI may reflect
the fact that HCWs communicate with or care for a
large number of people including patients, colleagues,
and relatives, and are thus exposed to a wide variety of
respiratory pathogens. The reduced risk for ARI in peo-
ple aged over 50 years might be explained by their
cumulative immune experience or a lower contact rate.
The apparent protective effect of smoking could be due
to lower ascertainment of ARI in this group, where a
background of smoking-related symptoms may have
masked the onset of an additional, mild infectious
respiratory illness. Conversely, respiratory symptoms
due to non-infectious causes may be over-reported in
non-smokers.
What significance does this study have for the current
H1N1v pandemic? As pandemic influenza should result
in a higher attack rate than seasonal influenza, the pre-
valence of influenza in hospital inpatients and staff is
likely to be higher than for seasonal influenza, so
increasing the risk of exposure and infection for HCWs
compared to that described here. For the same reasons,
the risk in HCWs and non-HCWs from their household
contacts would also be higher than for seasonal influ-
enza. Therefore even if a repeat study during pandemic
conditions identified a significant occupational risk for
HCWs, household exposures might still be more
strongly associated with influenza infection.
This study was subject to a number of limitations. As
recruiting at the hospital and one administrative study
Williams et al. BMC Infectious Diseases 2010, 10:8
http://www.biomedcentral.com/1471-2334/10/8
Page 9 of 11site was done through the occupational health depart-
ments, only a small proportion (fewer than 10%) of the
HCWs at these sites were enrolled in the study. Selec-
tion bias could have concealed any actual relationship
between HCWs status and influenza infection, if HCWs
with a lower risk of influenza than their non-recruited
colleagues were to have enrolled, or if non-HCWs with
a higher risk of influenza enrolled. It is possible that
HCWs with a higher number of patient contacts and,
t h e r e f o r ei nt h e o r yah i g h e rr isk of influenza, would be
less likely to participate due to pressure of work. Alter-
natively, HCWs who were concerned about their higher
risk of influenza may have protected themselves better
and may have been more likely than other HCWs to
participate, which would tend to decrease the relative
risk in this group.
Loss of recruited participants, mostly due to losses to
follow up (despite repeated attempts to contact) and to
the timing of vaccination, reduced the effective power of
the study and may have worsened selection bias,
although excluded participants did not differ signifi-
cantly with respect to variables found to influence the
outcome.
Although there were differences between the two
comparison groups with respect to sex, recent immuni-
sation, smoking and use of public transport, the logistic
regression methods should have adjusted for these
where they had an effect on the outcome (in particular
immunisation). The lower average age and higher pro-
portion of females in the HCW group is likely to be due
to recruitment among trainee nurses in the larger
hospitals.
Serological testing for influenza infection alone, rather
than molecular testing methods, may have underesti-
mated the true number of influenza infections [24].
This, along with the relatively high vaccination uptake,
will have reduced the number of SCII and thus the
effective study power. With an attack rate of 10% in
non-healthcare workers, the sample size of 736 analysed
would not have been sufficient to detect a relative risk
below 1.8 (80% power, 5% significance).
We explored the possibility of influenza clustering due
to site-level group influences or localized influenza out-
breaks. Analysis of symptom onset dates revealed no
evidence of separate site-specific outbreaks, but instead
the epidemic curves at each study site followed the over-
all trend. In addition the multilevel analysis suggested
that there were no significant group-level influences on
the outcome.
Conclusions
Our study results suggest that HCWs in an acute hospi-
tal care setting are at no higher risk of influenza than
the general public, or that if they are, the increased risk
is modest. Household contacts, particularly children,
play an important role with individuals with three or
more children being at highest risk. Use of public trans-
port does not increase the risk of influenza, whereas (in
the absence of household children) car ownership does
seem to significantly increase the risk for influenza
infection, although the mechanism is unclear. Further
research would help to clarify the role of household
contacts of different age groups, the relevance of car
ownership, and whether subgroups of hospital HCWs -
or HCWs in other settings, such as in primary care, -
are at increased risk for influenza infection. Finally, the
ILI-syndrome is a poor marker for influenza infection,
suggesting that HCWs cannot rely on this syndrome if
they wish to confidently protect their patients but,
should instead be vaccinated.
Acknowledgements
Many thanks go to the following persons, without whose dedicated hard
work this study would not have been possible:
M. Peter-Saleh, H. Rudolph, P. Kuhnert, B. Tuchen, A. Ulrich (Vivantes
Healthcare); C. Beissert, I. Pawlow, C. Schmitt, G. Paulisch (Haema blood
donation services, Berlin); H. Lehmann, M. Hartwig (RKI, Influenza reference
laboratory), P. Noelle (Lette-Verein training college, Berlin), R. Hirschberg
(Veterinary School, Free University in Berlin); A. Schumann (Occupational
Health, RKI); S. Buda, I. Zuschneid, Y. Deleré, W Haas, D. Walter, S. Reiter, A.
Jansen, M. an der Heiden, R. Offergeld (Robert Koch Institute).
The study was conducted by the Robert Koch Institute, with funding
support from the Berufsgenossenschaft für Gesundheitsdienst und
Wohlfahrtswesen (BGW), an occupational health insurer. The BGW had some
early input into the study question and design, and two representatives are
co-authors of this article. However the BGW representatives did not
influence the execution of the study, nor did they alter the analysis or
interpretation of the results.
Author details
1Department for Infectious Disease Epidemiology, Robert Koch Institute,
Berlin, Germany.
2European Programme for Intervention Epidemiology
Training, ECDC, Stockholm, Sweden.
3Vivantes Healthcare, Berlin, Germany.
4Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtswesen,
Hamburg, Germany.
Authors’ contributions
CW, under the supervision of UB, led the study design, conducted the
analysis and drafted and updated the manuscript. CW had full access to all
the data in the study and takes responsibility for the integrity of the data
and the accuracy of the data analysis.
BS supervised laboratory testing and participated in manuscript review. GD
participated in the conduct of the study and the manuscript review. FG
assisted with the study execution and critically reviewed the manuscript. FH
participated in the design of the study, participated in the execution of the
study and critically reviewed the manuscript. GK participated in the
planning, methodological concepts, interpretation of results and manuscript
review. AN participated in the conduct of the study and the manuscript
review. UB designed the study, obtained funding, supervised and assisted
with its execution, supervised analysis and interpretation of data, and
critically reviewed the manuscript.
All authors confirmed that they have seen and approved the final version
and have no conflicts of interest.
Received: 9 June 2009
Accepted: 12 January 2010 Published: 12 January 2010
Williams et al. BMC Infectious Diseases 2010, 10:8
http://www.biomedcentral.com/1471-2334/10/8
Page 10 of 11References
1. STIKO: Mitteilung der Ständigen Impfkommission am Robert Koch-
Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am
Robert Koch-Institut/Stand: Juli 2005. Epidemiologisches Bulletin 2005, , 30:
263.
2. Fiore AE, Shay DK, Haber P, Iskander JK, Uveki TM, Mootrey G, Bresee JS,
Cox NJ: Prevention and control of influenza. MMWR Morb Mortal Wkly Rep
2007, 56(RR06):1-54http://www.cdc.gov/mmwr/preview/mmwrhtml/
rr5606a1.htm?s_cid=rr5606a1_e.
3. World Health Organisation: Influenza Vaccines: WHO position Paper. Wkly
Epidemiol Rec 2005, 80:279-288.
4. Evans ME, Hall KL, Berry SE: Influenza control in acute care hospitals. Am J
of Infect Control 1997, 25:357-386.
5. Horcajada JP, Pumarola T, Martínez JA, Tapias G, Bayas JM, de la Prada M,
García F, Codina C, Gatell JM, Jiménez de, Anta MT: A nosocomial
outbreak of influenza during a period without influenza epidemic
activity. Eur Respir J 2003, 21:303-307.
6. Maltezou H: Nosocomial Influenza: new concepts and practice. Curr Opin
Infect Dis 2008, 21:337-343.
7. Salgado CD, Giannetta ET, Hayden FG, Farr BM: Preventing nosocomial
influenza by improving the vaccine acceptance rate of clinicians. Infect
Control Hosp Epidemiol 2004, 25:923-928.
8. Adal KA, Flowers RH, Anglim AM, Hayden FG, Titus MG, Coyner BJ, Farr BM:
Prevention of nosocomial influenza. Infect Control Hosp Epidemiol 1996,
17:641-648.
9. Elder AG, O’Donnell B, McCruden EA, Symington IS, Carman WF: Incidence
and recall of influenza in a cohort of Glasgow healthcare workers during
the 1993-4 epidemic: results of serum testing and questionnaire. BMJ
1996, 313:1241-1242.
10. Wilde JA, McMillan JA, Serwint J, Butta J, O’Riordan MA, Steinhoff MC:
Effectiveness of influenza vaccine in health care professionals: a
randomized trial. JAMA 1999, 281:908-913.
11. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S,
Valleron AJ: Time lines of infection and disease in human influenza: a
review of volunteer challenge studies. Am J Epidemiol 2008, 167:775-785.
12. Arbeitsgemeinschaft Influenza: Influenzavirus-Nachweise im Nationalen
Referenzzentrum (NRZ), Brandenburg/Berlin - vergangene Saison 2006/
2007. Influenza Working Group hosted by the Robert Koch Institute
websitehttp://influenza.rki.de/index.html?l=beb&grs=13.
13. Hastings L, Stuart J, Andrews N, Begg N: A retrospective survey of clusters
of meningococcal disease in England and Wales, 1993 to 1995:
estimated risks of further cases in household and educational settings.
Commun Dis Rep CDR Rev 1997, 7:R195-200.
14. Michiels B, Philips H, Coenen S, Yane F, Steinhauser T, Stuyck S, Denekens J,
Van Royen P: The effect of giving influenza vaccination to general
practitioners: a controlled trial [NCT00221676]. BMC Med 2006 10(4):17.
15. Viboud C, Boëlle P, Cauchemez S, Lavenu A, Valleron A, Antoine Flahault,
Carrat F: Risk factors of influenza transmission in households. Br J Gen
Pract 2004, 54:684-689.
16. Reichert TA, Sugaya N, Fedson DS, Glezen P, Simonsen L, Tashiro M: The
Japanese experience with vaccination schoolchildren against influenza.
N Engl J Med 2001, 344:889-96.
17. Glezen WP, Couch RB: Interpandemic influenza in the Houston area,
1974-76. N Engl J Med 1978, 298:587-92.
18. Oeltmann JE, Oren E, Haddad MB, Lake L, Harrington TA, Ijaz K, Narita M:
Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004.
Emerg Infect Dis 2006, 12:1156-9.
19. Wu J, Xu F, Zhou W, Feikin DR, Lin CY, He X, Zhu Z, Liang W, Chin DP,
Schuchat A: Risk factors for SARS among persons without known contact
with SARS patients, Beijing, China. Emerg Infect Dis 2004, 10:210-6.
20. World Health Organization Writing Group. Nonpharmaceutical
interventions for pandemic influenza, national and community
measures. Emerg Infect Dis 2006, 12:88-94.
21. Sadique MZ, Edmunds WJ, Smith RD, Meerding WJ, de Zwart O, Brug J,
Beutels P: Precautionary behavior in response to perceived threat of
pandemic influenza. Emerg Infect Dis 2007, 13:1307-1313.
22. Moore M, Valway SE, Ihle W, Onorato IM: A train passenger with
pulmonary tuberculosis: evidence of limited transmission during travel.
Clin Infect Dis 1999, 28:52-56.
23. Mangili A, Gendreau MA: Transmission of infectious diseases during
commercial air travel. Lancet 2005, 365:989-996.
24. Zambon M, Hays J, Webster A, Newman R, Keene O: Diagnosis of
influenza in the community: relationship of clinical diagnosis to
confirmed virological, serologic, or molecular detection of influenza. Arch
Intern Med 2001, 161:2116-22.
Pre-publication history
The pre-publication history for this paper can be accessed here:http://www.
biomedcentral.com/1471-2334/10/8/prepub
doi:10.1186/1471-2334-10-8
Cite this article as: Williams et al.: Seasonal influenza risk in hospital
healthcare workers is more strongly associated with household than
occupational exposures: results from a prospective cohort study in
Berlin, Germany, 2006/07. BMC Infectious Diseases 2010 10:8.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Williams et al. BMC Infectious Diseases 2010, 10:8
http://www.biomedcentral.com/1471-2334/10/8
Page 11 of 11